- Home
- BMY vs UL Comparison
BMY vs UL Comparison
Compare BMY & UL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMY | UL |
|---|---|---|
| Founded | 1887 | 1930 |
| Country | United States | United Kingdom |
| Employees | 32500 | 96092 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 125.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMY | UL |
|---|---|---|
| Price | $57.46 | $60.60 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $61.73 | N/A |
| AVG Volume (30 Days) | ★ 12.1M | 4.1M |
| Earning Date | 04-30-2026 | 03-12-2026 |
| Dividend Yield | ★ 4.38% | 4.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.53 |
| Revenue Next Year | N/A | $3.78 |
| P/E Ratio | $17.26 | ★ $14.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.52 | $54.75 |
| 52 Week High | $62.89 | $74.98 |
Technical Indicators
Market Signals| Indicator | BMY | UL |
|---|---|---|
| Relative Strength Index (RSI) | 54.26 | 62.46 |
| Support Level | $56.36 | $60.16 |
| Resistance Level | $57.43 | $61.14 |
| Average True Range (ATR) | 1.38 | 0.78 |
| MACD | 0.11 | 0.36 |
| Stochastic Oscillator | 85.81 | 89.92 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About UL Unilever PLC
Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.